U
Unicycive Therapeutics, Inc. (UNCY)
NCM – Real Time Price. Currency in USD
7.13
-1.08 (-13.15%)
At close: Jun 26, 2026, 4:00 PM EDT
7.36
+0.23 (3.29%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
7.13
-1.08 (-13.15%)
At close: Jun 26, 2026, 4:00 PM EDT
7.36
+0.23 (3.29%)
After-hours: Jun 26, 2026, 7:59 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $37.4M significantly exceed its total debt $941.0K, ensuring strong financial flexibility
Total current assets $63.5M exceed Total current liabilities $26.5M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$6.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.40 | 6.05 | 10 | |
| Quick ratio | 2.40 | 5.63 | 10 | |
| Debt to Equity | 0.03 | 0.30 | 9.0 | |
| Debt to Assets | 0.01 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 951K | 675K | N/A | N/A | N/A |
| Gross Profit | 944K | 391K | -428K | -572K | -648K |
| Operating Income | -18M | -21M | -32M | -30M | -30M |
| Net Income | -18M | -31M | -37M | -27M | -40M |
| EBITDA | -18M | -20M | -32M | -29M | -29M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -5.34 | 1.0 |
| Next quarter | N/A | 28.31 | 5.5 |
| Current year | N/A | 14.4 | 4.5 |
| Next year | 1963.24 | 514.49 | 10 |
| Weighted average score | 5.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 12.58 | -68.74 | 22.2 | 7.3 |
| Y/Y | 999 | -2614.3 | -7.99 | 29.94 | 5.5 |
| 3y average | 290 | -20.55 | 39.92 | -27.6 | 5.5 |
| 5y average | 573.6 | -96.86 | 20.06 | -110.02 | 5.5 |
| Weighted average score | 6.0 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |